Vor Biopharma Inc Working Capital to Net Assets Ratio
Vor Biopharma Inc working capital to net assets ratio. Vor Biopharma Inc (VOR) has a Working Capital to Net Assets ratio of -224.9% as of June 2026. Working capital of $450.29 Million (current assets of $475.11 Million minus current liabilities of $24.81 Million) is measured against net assets of $-200.20 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Vor Biopharma Inc's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Vor Biopharma Inc (2018–2025)
Working capital to net assets ratio of Vor Biopharma Inc from 2018 to 2025. This chart shows how Vor Biopharma Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the ratio stands at -224.9%, reflecting working capital of $450.29 Million against net assets of $-200.20 Million USD. See operational self-sufficiency of Vor Biopharma Inc to measure how many days the company can operate on defensive assets alone.
Vor Biopharma Inc Working Capital to Net Assets Ratio by Year (2018–2025)
Vor Biopharma Inc working capital to net assets ratio by year from 2018 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Vor Biopharma Inc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is Vor Biopharma Inc's balance sheet.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -263.5% | $432.93 Million | $-164.31 Million | $458.11 Million | $25.17 Million | ▼ -344.1 pp |
| 2024 | 80.6% | $77.89 Million | $96.66 Million | $96.51 Million | $18.61 Million | ▼ -2.5 pp |
| 2023 | 83.1% | $125.23 Million | $150.72 Million | $140.80 Million | $15.57 Million | ▼ -6.2 pp |
| 2022 | 89.3% | $223.83 Million | $250.61 Million | $236.95 Million | $13.12 Million | ▼ -5.1 pp |
| 2021 | 94.4% | $204.25 Million | $216.26 Million | $214.40 Million | $10.15 Million | ▲ +13.9 pp |
| 2020 | 80.6% | $38.90 Million | $48.27 Million | $49.11 Million | $10.21 Million | ▲ +10.5 pp |
| 2019 | 70.1% | $5.35 Million | $7.64 Million | $7.54 Million | $2.19 Million | ▼ -31.0 pp |
| 2018 | 101.0% | $-6.84 Million | $-6.77 Million | $936.00K | $7.77 Million | — |